Evidence map›Paper›PMID 35008203›Full record

ArticleCancers2021

DNA Methylation in

Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A Kuczyk and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Olga KatzendornDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Inga PetersDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0001-7549-9342
Natalia DubrowinskajaDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Joana M MoogDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Christel ReeseDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Hossein TezvalDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Pouriya Faraj TabriziDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Jörg HennenlotterDepartment of Urology, Eberhard Karls University of Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0003-3827-6996
Marcel LafosDepartment of Pathology, Hannover Medical School, 30625 Hannover, Germany.
Markus A KuczykDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Jürgen SerthDepartment of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany.
Medizinische Hochschule Hannover · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of DNA methylation in primary tumor tissues could be relevant for early stratification of aggressive renal cell carcinomas (RCCs) as a basis for future personalized adjuvant therapy. Methylated TCGA KIRC based candidate CpG loci in

Indexed as

hypermethylationINAmetastasisNHLH2prognosisrenal cell carcinomasignatureTHBS4

Identifiers

PMID35008203
PMCPMC8750163
OpenAlexW4200472447

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.